Your browser doesn't support javascript.
loading
Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer.
Anbari, Yasaman; Veerman, Floortje E; Keane, Grace; Braat, Arthur J A T; Smits, Maarten L J; Bruijnen, Rutger C G; Tan, Wenle; Li, Ye; Duan, Feng; Lam, Marnix G E H.
Afiliação
  • Anbari Y; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Veerman FE; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Keane G; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Braat AJAT; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Smits MLJ; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Bruijnen RCG; University Medical Center Utrecht, Utrecht, the Netherlands.
  • Tan W; Interventional Radiology Department, Chinese PLA General Hospital, Beijing, China.
  • Li Y; Interventional Radiology Department, Chinese PLA General Hospital, Beijing, China.
  • Duan F; Interventional Radiology Department, Chinese PLA General Hospital, Beijing, China.
  • Lam MGEH; University Medical Center Utrecht, Utrecht, the Netherlands.
J Interv Med ; 6(4): 153-159, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38312126
ABSTRACT
Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Interv Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Interv Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda